We are live on ! Find out more
JLBC

J.L. Bainbridge & Co Portfolio holdings

AUM $1.27B
1-Year Est. Return 26.55%
This Fund
S&P 500
This Quarter Est. Return
-4.96%
1 Year Est. Return
+26.55%
3 Year Est. Return
+93.81%
5 Year Est. Return
+120.16%
10 Year Est. Return
AUM
$653M
AUM Growth
-$19.6M
Cap. Flow
+$28.5M
Cap. Flow %
4.37%
Top 10 Hldgs %
67.26%
Holding
76
New
Increased
25
Reduced
24
Closed
5

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$21.8M
2
AXP icon
American Express
AXP
+$13.6M
3
CMCSA icon
Comcast
CMCSA
+$1M
4
T icon
AT&T
T
+$813K
5
QCOM icon
Qualcomm
QCOM
+$584K

Sector Composition

Rank Sector Weight
1 Technology 37.23%
2 Communication Services 23.37%
3 Healthcare 11.21%
4 Financials 8.14%
5 Industrials 7.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVC
51
Service Properties Trust
SVC
$1.02B
$340K 0.05%
13,106
-69
-0.5% -$2.29K
JPM icon
52
JPMorgan Chase
JPM
$951B
$325K 0.05%
3,111
+31
+1% +$3.56K
VZ icon
53
Verizon
VZ
$208B
$300K 0.05%
7,893
-107
-1% -$4.76K
BAC icon
54
Bank of America
BAC
$436B
$297K 0.05%
9,824
+1,500
+18% +$50.1K
SPGI icon
55
S&P Global
SPGI
$131B
$277K 0.04%
906
-2
-0.2% -$716
PFE icon
56
Pfizer
PFE
$159B
$252K 0.04%
5,769
+1,002
+21% +$48.7K
IBDP
57
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$252K 0.04%
10,366
INTC icon
58
Intel
INTC
$473B
$242K 0.04%
9,404
-666
-7% -$22.7K
IGIB icon
59
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.7B
$236K 0.04%
4,887
-1
-0% -$51
XYL icon
60
Xylem
XYL
$26B
$236K 0.04%
2,700
RY icon
61
Royal Bank of Canada
RY
$283B
$225K 0.03%
2,500
FNDA icon
62
Schwab Fundamental US Small Company Index ETF
FNDA
$9.15B
$224K 0.03%
10,532
TFC icon
63
Truist Financial
TFC
$61.6B
$224K 0.03%
5,141
COST icon
64
Costco
COST
$419B
$220K 0.03%
466
ABBV icon
65
AbbVie
ABBV
$451B
$216K 0.03%
1,611
+54
+3% +$7.75K
NSC icon
66
Norfolk Southern
NSC
$78.3B
$210K 0.03%
1,000
IJR icon
67
iShares Core S&P Small-Cap ETF
IJR
$110B
$208K 0.03%
2,387
+50
+2% +$4.86K
PEP icon
68
PepsiCo
PEP
$193B
$207K 0.03%
1,269
RYAM icon
69
Rayonier Advanced Materials
RYAM
$582M
$204K 0.03%
64,665
+25,100
+63% +$100K
ESBA icon
70
Empire State Realty Series ES
ESBA
$1.3B
$155K 0.02%
24,206
ATOS icon
71
Atossa Therapeutics
ATOS
$25.7M
$9K ﹤0.01%
708
CVS icon
72
CVS Health
CVS
$119B
-2,891
Closed -$268K
LMT icon
73
Lockheed Martin
LMT
$130B
-470
Closed -$202K
MRK icon
74
Merck
MRK
$366B
-5,885
Closed -$537K
OTIS icon
75
Otis Worldwide
OTIS
$27.3B
-3,066
Closed -$217K

Similar funds

J.L. Bainbridge & Co's Q3 2022 Portfolio in Review

As of Q3 2022, J.L. Bainbridge & Co held 76 positions worth $653M, down 2.9% from $673M the previous quarter. Its ten largest holdings account for 67% of the portfolio.

J.L. Bainbridge & Co deployed $28.5M of net new capital in Q3 2022, adding to 25 existing holdings.

By sector, the portfolio is most concentrated in Technology at 37% of assets, down from 38% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Apple, an estimated $1.86M trimmed.

  • J.L. Bainbridge & Co added most to Eaton in Q3 2022, an estimated $21.8M increase.
  • J.L. Bainbridge & Co's biggest Q3 2022 reduction was Apple, cutting an estimated $1.86M.
  • J.L. Bainbridge & Co fully exited Merck in Q3 2022, selling an estimated $537K.
  • J.L. Bainbridge & Co's ten largest holdings make up 67% of its $653M portfolio in Q3 2022.
  • J.L. Bainbridge & Co opened 0 new positions and closed 5 in Q3 2022.
  • J.L. Bainbridge & Co's portfolio value fell 2.9% quarter-over-quarter to $653M.

Based on J.L. Bainbridge & Co's 13F filing for Q3 2022, filed 2 Nov 2022.